Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
50%
Ph not_applicable
1
50%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

2

all time

Status Distribution
Active(1)
Completed(1)

Detailed Status

Completed1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
2
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (50.0%)
N/A1 (50.0%)

Trials by Status

completed150%
enrolling_by_invitation150%

Recent Activity

0 active trials
Showing 2 of 2
completedphase_2

Phase II Study of Feasibility of Focal Therapy for Prostate Cancer of Good Prognosis With Permanent I125 Localized Implant.

NCT01902680
enrolling_by_invitationnot_applicable

Cancer of the Prostate Treated With Focal Implantation of a RadioactivE Source

NCT06080113

Clinical Trials (2)

Showing 2 of 2 trials
NCT01902680Phase 2

Phase II Study of Feasibility of Focal Therapy for Prostate Cancer of Good Prognosis With Permanent I125 Localized Implant.

Completed
NCT06080113Not Applicable

Cancer of the Prostate Treated With Focal Implantation of a RadioactivE Source

Enrolling By Invitation

All 2 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
2